Drug Database
Back to search

United States· US:68382-255_f54e4d4e-91be-4e10-a446-57ed5e1843a1

oxybutynin

A oxybutynin product containing oxybutynin chloride, registered in United States by Zydus Pharmaceuticals USA Inc.. The same ATC class is registered in 18 of our 19 countries.

ATC G04BD04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedoxybutyninATCG04BD04REGISTER NO.US:68382-255_f54e4d4e…PACKS LISTED12CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxybutynin chlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxybutynin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD04 (oxybutynin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search oxybutynin products by name

Oxybutynin · ATC G04BD04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxybutynin costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.17 in France to $2.99 in Switzerland — a ×18 gap.

  • United States: $0.20 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Oxybutynin · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.99
  • IT Italy$0.59
  • US United States$0.20 (acquisition cost)
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OXYBUTYNIN CHLORIDE
Manufacturer
Zydus Pharmaceuticals USA Inc.
Country
United States (US)
ATC code
G04BD04
ATC class
Oxybutynin
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 12

  • ndc11
    68382-255-01
  • ndc11
    68382-255-05
  • ndc11
    68382-255-06
  • ndc11
    68382-255-14
  • ndc11
    68382-255-16
  • ndc11
    68382-255-77
  • ndc11
    6838225501
    100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-01)
  • ndc11
    6838225505
    500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-05)
  • ndc11
    6838225506
    30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-06)
  • ndc11
    6838225514
    60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-14)
  • ndc11
    6838225516
    90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-16)
  • ndc11
    6838225577
    10 BLISTER PACK in 1 CARTON (68382-255-77) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68382-255-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

312 interactions on record for oxybutynin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxybutynin against other medicinesHow interaction checks work

Oxybutynin · interactions on record

312 records

  • 3 severe
  • 103 moderate
  • 1 minor
  • 168 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate

37 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxybutynin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxybutynin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Detrusan, Ditropan
  • Belgium · Oxybutynine Eg, Velariq
  • Bulgaria · Дриптан
  • Czechia · Tarraconiq, Uroxal
  • Germany · Dridase, Oxybutynin Aaa-Pharma
  • Denmark · Oxybutynin Macure, Oxybutynin Unimedic
  • Estonia · Driptane
  • Spain · Ditropan, Dresplan
  • Finland · Oxybutynin Macure, Oxybutynin Unimedic
  • France · Ditropan, Oxybutynine Accord
  • United Kingdom (Northern Ireland) · Ditropan, Oxybutynin Hydrochloride
  • Greece · Ditropan
  • Hungary · Ditropan, Uroxal
  • Ireland · Oxybutynin Hydrochloride Accord Healthcare Ireland, Oxybutynin Hydrochloride Syri Pharma
  • Iceland · Kentera
  • Italy · Ditropan, Ossibutinina Cloridrato Mylan Generics
  • Liechtenstein · Kentera
  • Lithuania · Driptane
  • Luxembourg · Oxybutynine Eg, Velariq
  • Latvia · Driptane
  • Netherlands · Dridase, Oxybutinin Hydrochloride Aurobindo
  • Norway · Kentera, Oxybutynin Macure
  • Poland · Ditropan, Driptane
  • Portugal · Ditropan, Velariq
  • Romania · Driptane
  • Sweden · Ditropan, Oxybutynin Accord
  • Slovakia · Uroxal, Velariq

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/70d42319-450b-4ae2-abad-a7ebfe28c259
GET /v1/drugs/70d42319-450b-4ae2-abad-a7ebfe28c259?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "OXYBUTYNIN CHLORIDE",
  "productndc": "68382-255",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202332",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about oxybutynin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console